ArticleNeuropsychopharmacology reports2025
Osmotic Demyelination Syndrome in a Patient With Schizophrenia: A Case Report.
Article in Neuropsychopharmacology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Osmotic Demyelination Syndrome in a Patient With Schizophrenia: A Case Report.Neuropsychopharmacology reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary polydipsia affects approximately 11%-20% of patients with chronic schizophrenia, and up to one-third develop symptomatic hyponatremia. Rapid correction of hyponatremia can precipitate osmotic demyelination syndrome (ODS), involving demyelination in the central pons and extrapontine regions. ODS presenting with severe extrapyramidal symptoms (EPS) in schizophrenia has not been previously documented. CASE PRESENTATION: A 34-year-old man with chronic schizophrenia, maintained on oral olanzapine and monthly flupentixol decanoate, developed polydipsia-induced hyponatremia. His serum sodium was corrected at 9 mEq/L/day at a local hospital. Ten days later, he presented with fever, cough, dysarthria, dysphagia, and lead-pipe rigidity. Laboratory tests revealed leukocytosis and rhabdomyolysis without delirium or autonomic instability. Dysarthria and dysphagia were consistent with pseudobulbar palsy. Brain MRI showed T2-weighted and FLAIR hyperintensities in the bilateral basal ganglia and central pons, confirming ODS. The patient had a favorable clinical course with supportive treatment and regained independent mobility without the need for empirical immunotherapy.
conclusionsThis case highlights ODS as a rare but critical differential diagnosis for severe EPS in schizophrenia, particularly when presenting with lead-pipe rigidity and pseudobulbar palsy. Greater awareness of this presentation can facilitate timely diagnosis and appropriate management, avoiding misattribution to antipsychotic-induced side effects that may result in long-term morbidity or mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.